Repligen Corporation(RGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RGEN Repligen Corporation

盘前交易 11-15 07:15:02 EST

142.43

-8.04

-5.34%

盘前142.19

-0.24-0.17%

07:14 EST

最高149.88	最低142.08	成交量74.83万
今开148.58	昨收150.47	日振幅5.18%
总市值79.77亿	流通市值74.36亿	总股本5,601万
成交额1.09亿	换手率1.43%	流通股本5,221万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RGEN","market":"US","secType":"STK","nameCN":"Repligen Corporation","latestPrice":142.43,"timestamp":1731618000000,"preClose":150.47,"halted":0,"volume":748296,"hourTrading":{"tag":"盘前","latestPrice":142.19,"preClose":142.43,"latestTime":"07:14 EST","volume":623,"amount":88644.30883000001,"timestamp":1731672895870},"delay":0,"floatShares":52208406,"shares":56006498,"eps":-0.037833,"marketStatus":"盘前交易","marketStatusCode":1,"change":-8.04,"latestTime":"11-15 07:15:02 EST","open":148.58,"high":149.88,"low":142.08,"amount":108635196.28392,"amplitude":0.051838,"askPrice":142.2,"askSize":1,"bidPrice":141.35,"bidSize":160,"shortable":3,"etf":0,"ttmEps":-0.037833,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731681000000},"adr":0,"adjPreClose":142.43,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":142.19,"preClose":142.43,"latestTime":"07:14 EST","volume":623,"amount":88644.30883000001,"timestamp":1731672895870},"postHourTrading":{"tag":"盘后","latestPrice":142.43,"preClose":142.43,"latestTime":"18:49 EST","volume":30155,"amount":4294889.85,"timestamp":1731628188547},"volumeRatio":0.9229963116536453,"impliedVol":0.5166,"impliedVolPercentile":0.6056},"requestUrl":"/m/hq/s/RGEN/wiki","defaultTab":"wiki","newsList":[{"id":"2483450334","title":"Repligen Corporation盘中异动 快速下挫5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483450334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483450334?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:41","pubTimestamp":1731616887,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时41分，Repligen Corporation股票出现异动，股价大幅跳水5.00%。截至发稿，该股报142.95美元/股，成交量48.4963万股，换手率0.87%，振幅4.55%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为0.23%。Repligen Corporation公司简介：Repligen 总部位于马萨诸塞州沃尔瑟姆，是一家全球生命科学公司，开发和销售用于制造生物药物的生物加工设备和用品，包括单克隆抗体、重组蛋白、疫苗以及细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115044127971a6a28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115044127971a6a28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","LU1815336091.USD","LU0757428866.USD","RGEN"],"gpt_icon":0},{"id":"2482638084","title":"Repligen 公司报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2482638084","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482638084?lang=zh_cn&edition=full","pubTime":"2024-11-12 23:27","pubTimestamp":1731425240,"startTime":"0","endTime":"0","summary":"Repligen 公司报告截至 9 月 30 日的季度业绩 - 收益摘要Repligen Corp RGEN.OQ公布的截至9月30日的季度调整后每股收益为43美分，高于去年同期的每股收益23美分。华尔街预期为每股收益 28 美分至 39 美分。Repligen 公司公布的本季度每股收益为亏损 1 美分。该公司的季度亏损额为 65.3 万美元。Repligen Corp 本季度股价下跌了 6.3%，今年迄今为止下跌了 22.4%。华尔街对 Repligen 公司 12 个月目标价的中位数为 190.00 本摘要由 LSEG 11 月 12 日 03:27 p.m. UTC 调制解调器器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nL4T3MJ1NU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1815336091.USD","RGEN","BK4121","LU0757428866.USD"],"gpt_icon":0},{"id":"2482208364","title":"Repligen Corporation盘中异动 早盘股价大涨5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482208364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482208364?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:30","pubTimestamp":1731421825,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时30分，Repligen Corporation股票出现异动，股价大幅拉升5.73%。Repligen Corporation股票所在的医疗设备行业中，整体涨幅为0.00%。Repligen Corporation公司简介：Repligen 总部位于马萨诸塞州沃尔瑟姆，是一家全球生命科学公司，开发和销售用于制造生物药物的生物加工设备和用品，包括单克隆抗体、重组蛋白、疫苗以及细胞和基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112223025abba4c8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112223025abba4c8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGEN","BK4121","LU1815336091.USD","LU0757428866.USD"],"gpt_icon":0},{"id":"2482700698","title":"BUZZ-Repligen 公司上调财年利润预期，业绩增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2482700698","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482700698?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:00","pubTimestamp":1731420026,"startTime":"0","endTime":"0","summary":"    11月12日 - ** 生物技术公司Repligen Corp   股价盘前上涨6.09%至148美元** 将财政年度调整后利润预期从每股1.42美元至1.49美元上调至1.50美元至1.58美元之间** 预计财年总营收介于 6.3 亿至 6.39 亿美元之间，此前预计为 6.2 亿至 6.35 亿美元。** 本季度 CDMO 和设备销售均实现了同比和环比增长，这令我们倍受鼓舞\"- RGEN** 净利润，RGEN 本季度表现稳健，前瞻性评论积极\"--Stephens 券商** 截至上次收盘，股价累计下跌 22.4","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1815336091.USD","LU0757428866.USD","RGEN","BK4121"],"gpt_icon":0},{"id":"2482484743","title":"Repligen Corp  预计每股收益 33 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482484743","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482484743?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:56","pubTimestamp":1731084970,"startTime":"0","endTime":"0","summary":"Repligen Corp  预计每股收益 33 美分 - 财报前瞻Repligen公司RGEN.OQRGEN.O将于11月12日公布截至2024年9月30日的财报，预计季度收入将有所增长。(DECY 季度业绩可能与年度业绩不符，原因是重报了实际业绩。)LSEG 分析师对 Repligen Corp 的平均预期为每股收益 33 美分。华尔街对 Repligen Corp 的 12 个月目标价中位数为 190.00 美元，高于其上次收盘价 143.88 美元。11月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4S3MF26N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGEN"],"gpt_icon":0},{"id":"2479308783","title":"Repligen Corp    预计每股收益 33 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2479308783","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479308783?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:36","pubTimestamp":1730295411,"startTime":"0","endTime":"0","summary":"   * Repligen公司   预计将在11月1日公布截至0001年1月1日的业绩报告时显示季度收入增长(，预计)。)   * LSEG 分析师对 Repligen Corp 的平均预期为每股收益 33 美分。* 华尔街对 Repligen Corp 的 12 个月目标价中位数为 190.00 美元，高于其最新收盘价 134.87 美元。10月30日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Repligen Corp    预计每股收益 33 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGEN"],"gpt_icon":0},{"id":"2476794676","title":"Repligen Corporation盘中异动 股价大跌5.07%报137.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476794676","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476794676?lang=zh_cn&edition=full","pubTime":"2024-10-17 00:10","pubTimestamp":1729095047,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日00时10分，Repligen Corporation股票出现波动，股价急速下跌5.07%。截至发稿，该股报137.63美元/股，成交量16.3176万股，换手率0.29%，振幅3.79%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为0.69%。其相关个股中，Nexgel Inc C/Wts 01/12/2026 、Zentek Ltd.、Singular Genomics Systems, Inc.涨幅较大，Avinger, Inc.、Sharps Technology Inc.、Bionano Genomics, Inc.较为活跃，换手率分别为6.65%、5.95%、3.56%，振幅较大的相关个股有Zentek Ltd.、Nexgel Inc C/Wts 01/12/2026 、中进医疗，振幅分别为20.13%、13.11%、10.80%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101700104798e3cd28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101700104798e3cd28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0757428866.USD","BK4121","RGEN","LU1815336091.USD"],"gpt_icon":0},{"id":"2470948734","title":"Repligen Corporation盘中异动 股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470948734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470948734?lang=zh_cn&edition=full","pubTime":"2024-09-26 21:35","pubTimestamp":1727357745,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日21时35分，Repligen Corporation股票出现异动，股价快速上涨5.15%。截至发稿，该股报146.79美元/股，成交量3.413万股，换手率0.06%，振幅2.48%。Repligen Corporation股票所在的医疗设备行业中，整体涨幅为0.31%。其相关个股中，Infusystems Holdings, Inc.、Nexgel, Inc、Repligen Corporation涨幅较大，Sharps Technology Inc.、Innovative Eyewear, Inc.、豪洛捷较为活跃，换手率分别为3.37%、3.34%、0.21%，振幅较大的相关个股有Innovative Eyewear, Inc.、哈佛生物科学、Bionano Genomics, Inc.，振幅分别为8.32%、3.76%、3.39%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926213546a1dcc149&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926213546a1dcc149&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","RGEN","LU1815336091.USD","LU0757428866.USD"],"gpt_icon":0},{"id":"2468558145","title":"Repligen Corporation盘中异动 急速上涨5.20%报143.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468558145","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468558145?lang=zh_cn&edition=full","pubTime":"2024-09-19 02:39","pubTimestamp":1726684789,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日02时39分，Repligen Corporation股票出现异动，股价急速上涨5.20%。截至发稿，该股报143.48美元/股，成交量40.6014万股，换手率0.72%，振幅4.89%。Repligen Corporation股票所在的医疗设备行业中，整体涨幅为0.37%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409190239499719bb57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409190239499719bb57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","RGEN","LU0757428866.USD","LU1815336091.USD"],"gpt_icon":0},{"id":"2460342310","title":"Repligen Corporation盘中异动 快速拉升5.06%报155.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460342310","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460342310?lang=zh_cn&edition=full","pubTime":"2024-08-19 21:39","pubTimestamp":1724074750,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日21时39分，Repligen Corporation股票出现异动，股价急速上涨5.06%。截至发稿，该股报155.01美元/股，成交量8.1964万股，换手率0.15%，振幅4.51%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为0.10%。其相关个股中，Sharps Technology Inc C/Wts 、Predictive Oncology Inc.、Repligen Corporation涨幅较大，Predictive Oncology Inc.、泰利福、Bionano Genomics, Inc.较为活跃，换手率分别为0.95%、0.51%、0.22%，振幅较大的相关个股有Nexgel, Inc、Repligen Corporation、Bionano Genomics, Inc.，振幅分别为7.28%、4.51%、3.74%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921391197199216&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921391197199216&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","RGEN","LU0757428866.USD","LU1815336091.USD"],"gpt_icon":0},{"id":"2460124271","title":"BUZZ-Repligen 因报告公司竞购 Maravai LifeSciences 而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2460124271","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460124271?lang=zh_cn&edition=full","pubTime":"2024-08-17 01:19","pubTimestamp":1723828774,"startTime":"0","endTime":"0","summary":"    8月16日 - ** 生物技术公司Repligen   股价下跌11.46%至143.97美元** 路透援引知情人士的话报导称，该公司正在竞购试剂供应商 Maravai LifeSciences Holdings     ** MRVI 股价上涨 21.71% 至 9.70 美元** 疫苗封口试剂供应商 Maravai 已成为收购目标，因为在大流行病消退后，Maravai 在 COVID-19 疫苗之外努力实现多样化，其价值从 2021 年 8 月的峰值下跌了近 80%。** RGEN 股价下跌了约 22%，而 MRVI 股价则上涨了约 47%，YTD","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","BK4121","LU1815336091.USD","MRVI","LU0757428866.USD","RGEN"],"gpt_icon":0},{"id":"2459659246","title":"独家-消息人士称 Repligen 有意收购试剂供应商 Maravai","url":"https://stock-news.laohu8.com/highlight/detail?id=2459659246","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459659246?lang=zh_cn&edition=full","pubTime":"2024-08-16 23:39","pubTimestamp":1723822758,"startTime":"0","endTime":"0","summary":" Anirban Sen    路透8月16日 - 熟悉内情的人士周五表示，药品生产设备供应商Repligen   已向市值22亿美元的疫苗封口试剂供应商Maravai LifeSciences Holdings   提出收购要约。消息人士称，目前还不能确定Maravai是否会同意与Repligen的交易。其中一位消息人士补充说，Repligen公司还在考虑，如果成功收购Maravai公司，是否应该剥离Maravai公司的一些部门。消息人士要求匿名，因为此事属于机密。Repligen和Maravai的发言人没有立即回应置评请求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","LU0757428866.USD","LU1815336091.USD","RGEN","MRVI"],"gpt_icon":0},{"id":"2459246257","title":"Repligen Corporation盘中异动 临近午盘快速跳水5.38%报153.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459246257","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459246257?lang=zh_cn&edition=full","pubTime":"2024-08-16 23:35","pubTimestamp":1723822515,"startTime":"0","endTime":"0","summary":"北京时间2024年08月16日23时35分，Repligen Corporation股票出现异动，股价大幅跳水5.38%。截至发稿，该股报153.86美元/股，成交量11.6492万股，换手率0.21%，振幅4.73%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为0.02%。其相关个股中，Ekso Bionics Holdings, Inc.、Glucotrack, Inc.、Staar Surgical Company涨幅较大，Bionano Genomics, Inc.、Innovative Eyewear, Inc.、Glucotrack, Inc.较为活跃，换手率分别为2.30%、1.52%、0.67%，振幅较大的相关个股有Glucotrack, Inc.、Nexgel Inc C/Wts 01/12/2026 、Bionano Genomics, Inc.，振幅分别为22.44%、20.16%、14.86%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081623351598e3532a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081623351598e3532a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","RGEN","LU0757428866.USD","LU1815336091.USD"],"gpt_icon":0},{"id":"2457761077","title":"Repligen Corporation盘中异动 急速下挫5.34%报153.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457761077","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457761077?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:33","pubTimestamp":1722864815,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时33分，Repligen Corporation股票出现波动，股价急速下挫5.34%。截至发稿，该股报153.04美元/股，成交量1.2558万股，换手率0.02%，振幅1.95%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为1.43%。其相关个股中，West Pharmaceutical Services, Inc.、Warby Parker Inc.、犹他医疗产品涨幅较大，Sharps Technology Inc.、Predictive Oncology Inc.、Innovative Eyewear, Inc.较为活跃，换手率分别为1.71%、1.27%、0.98%，振幅较大的相关个股有Nexgel, Inc、Femasys Inc.、美华国际，振幅分别为7.09%、5.05%、4.95%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213335957f2ef4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213335957f2ef4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGEN","BK4121"],"gpt_icon":0},{"id":"2456218221","title":"Repligen Corporation2024财年第二财季实现净利润3.32百万美元，同比减少83.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456218221","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456218221?lang=zh_cn&edition=full","pubTime":"2024-08-04 00:16","pubTimestamp":1722701769,"startTime":"0","endTime":"0","summary":"8月4日，Repligen Corporation公布财报，公告显示公司2024财年第二财季净利润为3.32百万美元，同比减少83.45%；其中营业收入为1.54亿美元，同比减少3.14%，每股基本收益为0.06美元。从资产负债表来看，Repligen Corporation总负债8.76亿美元，其中短期债务81.61百万美元，资产负债比为3.27，流动比率为6.67。机构评级：截至2024年8月4日，当前有11家机构对Repligen Corporation目标价做出预测，其中目标均价为193.36美元，其中最低目标价为160.00美元，最高目标价为225.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240804001612957ab178&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240804001612957ab178&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGEN"],"gpt_icon":0},{"id":"2456280226","title":"Repligen Corporation盘中异动 早盘快速下跌5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456280226","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456280226?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:37","pubTimestamp":1722605836,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时37分，Repligen Corporation股票出现异动，股价大幅下挫5.59%。截至发稿，该股报156.41美元/股，成交量1.8567万股，换手率0.03%，振幅2.06%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为0.43%。其相关个股中，Merit Medical Systems, Inc.、Milestone Scientific, Inc.、勒梅特微管医疗涨幅较大，Sharps Technology Inc.、Predictive Oncology Inc.、美华国际较为活跃，换手率分别为1.30%、1.08%、0.49%，振幅较大的相关个股有Merit Medical Systems, Inc.、Zentek Ltd.、Sharps Technology Inc.，振幅分别为7.72%、7.57%、6.88%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213716aefcf8f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213716aefcf8f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RGEN","BK4121"],"gpt_icon":0},{"id":"2455159972","title":"Repligen Corporation盘中异动 临近午盘股价大涨5.03%报168.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455159972","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455159972?lang=zh_cn&edition=full","pubTime":"2024-07-31 23:42","pubTimestamp":1722440545,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日23时42分，Repligen Corporation股票出现波动，股价快速拉升5.03%。截至发稿，该股报168.66美元/股，成交量61.2483万股，换手率1.09%，振幅5.94%。Repligen Corporation股票所在的医疗设备行业中，整体涨幅为1.78%。其相关个股中，Nexgel Inc C/Wts 01/12/2026 、Avinger, Inc.、Milestone Scientific, Inc.涨幅较大，美华国际、Predictive Oncology Inc.、Innovative Eyewear, Inc.较为活跃，换手率分别为226.81%、5.11%、4.90%，振幅较大的相关个股有美华国际、Nexgel Inc C/Wts 01/12/2026 、AtriCure，振幅分别为51.36%、17.94%、15.59%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731234225af9526ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240731234225af9526ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","RGEN"],"gpt_icon":0},{"id":"2455530951","title":"加拿大皇家银行：重申Repligen(RGEN.US)评级，由优于大市调整至优于大市评级, 目标价由190.00美元调整至190.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455530951","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455530951?lang=zh_cn&edition=full","pubTime":"2024-07-31 23:08","pubTimestamp":1722438538,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RGEN","BK4121"],"gpt_icon":0},{"id":"2455379799","title":"Repligen Corporation盘中异动 股价大涨9.08%报150.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455379799","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455379799?lang=zh_cn&edition=full","pubTime":"2024-07-30 21:31","pubTimestamp":1722346315,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日21时31分，Repligen Corporation股票出现波动，股价急速上涨9.08%。截至发稿，该股报150.53美元/股，成交量6.6313万股，换手率0.12%，振幅3.35%。Repligen Corporation股票所在的医疗设备行业中，整体涨幅为0.07%。其相关个股中，Repligen Corporation、Zentek Ltd.、Pulse Biosciences, Inc涨幅较大，Predictive Oncology Inc.、Ekso Bionics Holdings, Inc.、Sharps Technology Inc.较为活跃，换手率分别为0.94%、0.64%、0.52%，振幅较大的相关个股有Ekso Bionics Holdings, Inc.、Femasys Inc.、勒梅特微管医疗，振幅分别为9.37%、5.11%、3.37%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407302131559efda869&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407302131559efda869&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","RGEN"],"gpt_icon":0},{"id":"2454822326","title":"Repligen Corp    预计每股收益 33 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2454822326","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454822326?lang=zh_cn&edition=full","pubTime":"2024-07-26 22:35","pubTimestamp":1722004510,"startTime":"0","endTime":"0","summary":"   * Repligen公司   将于7月30日公布截至2024年6月30日的季度业绩报告，预计该公司的季度收入将出现下降。* LSEG分析师对Repligen公司的平均预期为每股收益33美分。* 华尔街对 Repligen Corp 的 12 个月目标价中位数为 197.79 美元，高于其上次收盘价 132.36 美元。7月26日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RGEN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.repligen.com","stockEarnings":[{"period":"1week","weight":-0.0101},{"period":"1month","weight":-0.0176},{"period":"3month","weight":-0.0347},{"period":"6month","weight":-0.1716},{"period":"1year","weight":-0.0866},{"period":"ytd","weight":-0.2078}],"compareEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.0704},{"period":"6month","weight":0.1207},{"period":"1year","weight":0.3195},{"period":"ytd","weight":0.2483}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Repligen Corporation是供应生物制药关键产品的领军者。公司生产的蛋白质A为重要生命科学研究公司提供长期供应、长期合约，并同时直接向制药加工链终端使用者销售。公司向SecreFlo公司最新的药物提供专业生物研发产品，这种药物已经向美国食品药品行政管理局递交申请并已获得优先检验，公司已向欧洲药物管理机构递交了市场授权许可。SecreFlo是研发诊断胰腺炎和多种潜在胰腺疾病的合成人类激素药物新型显像剂的企业。公司进行两个早期中枢神经系统罕见疾病项目研究，弗里德里希运动失调和脊柱肌肉萎缩进入到了临床试验的第一阶段。此外，公司已从Bristol-Myers Squibb公司获得知识产权的额外许可——该公司可在美国对药物阿巴西普实价销售的专利权。公司于1981年5月成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.684211,"avgChangeRate":0.094555},{"month":2,"riseRate":0.421053,"avgChangeRate":0.031694},{"month":3,"riseRate":0.552632,"avgChangeRate":0.040702},{"month":4,"riseRate":0.473684,"avgChangeRate":-0.005601},{"month":5,"riseRate":0.564103,"avgChangeRate":0.050728},{"month":6,"riseRate":0.461538,"avgChangeRate":-0.012809},{"month":7,"riseRate":0.512821,"avgChangeRate":0.031555},{"month":8,"riseRate":0.564103,"avgChangeRate":0.029569},{"month":9,"riseRate":0.358974,"avgChangeRate":-0.039812},{"month":10,"riseRate":0.461538,"avgChangeRate":0.023419},{"month":11,"riseRate":0.461538,"avgChangeRate":0.028449},{"month":12,"riseRate":0.5,"avgChangeRate":-0.001659}],"exchange":"NASDAQ","name":"Repligen Corporation","nameEN":"Repligen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Repligen Corporation(RGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Repligen Corporation(RGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Repligen Corporation,RGEN,Repligen Corporation股票,Repligen Corporation股票老虎,Repligen Corporation股票老虎国际,Repligen Corporation行情,Repligen Corporation股票行情,Repligen Corporation股价,Repligen Corporation股市,Repligen Corporation股票价格,Repligen Corporation股票交易,Repligen Corporation股票购买,Repligen Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Repligen Corporation(RGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Repligen Corporation(RGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}